Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.

Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N
Elife. 2017 Feb 13;6. doi: 10.7554/eLife.20183. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.